Avomeen Announces New President

April 8, 2015
Pharmaceutical Technology Editors

Avomeen Analytical Services announces that David W. Riggs, PE will take the role of president of the company.

 

Avomeen Analytical Services announced on April 7, 2015 that it would appoint David W. Riggs as president of the company. Riggs will join Avomeen with almost 30 years of experience in advanced analytical chemistry, product development, chemical engineering, and other roles within the industry.

“David brings excellent credentials into our growing laboratory; his dedication to building successful relationships with clients through long-term mutually beneficial business partnerships is to be admired.  He has the vision and ambition to take Avomeen to the next level and comes highly recommended from within the industry.  David brings to Avomeen his experience with sales integrations, acquisitions, and the launch of new testing opportunities,” said Shri Thanedar, PhD, CEO of Avomeen Analytical Services, in a press release.

Avomeen is a full-service chemical testing laboratory with product testing and formulation development services. The company specializes in deformulation analysis (reverse engineering), product development, stability testing, pharmaceutical research and development, litigation support services, and pharmaceutical product lifecycle support.

Source: Avomeen

Related Content:

PharmTech News | Supplier News